The global Imaging in Structural Heart Disease Market size is expected to reach USD 34.1 billion in 2028 at a CAGR of 10.2%, according to a new report by Reports and Data. Increasing prevalence of structural heart diseases, rising awareness about cardiac health, surging prevalence of lifestyle-induced diseases such as diabetes and high blood pressure, and increasing unhealthy habits such as excessive alcohol consumption and drug abuse are among some factors expected to drive global market revenue growth going ahead. Other key factors boosting market growth are technological advancements in Imaging in Structural Heart Disease modalities, rapid adoption of advanced imaging techniques, increasing clinical trials of emerging cardiac imaging techniques, and increasing government support for healthcare RD activities. Market players’ increased focus on expanding existing product portfolio and a favorable regulatory scenario for structural heart procedures are expected to stimulate market growth in the near future.
Imaging in Structural Heart Disease (SHI) is an imaging technique that employs high-resolution cameras for screening of the heart to produce clear images, which aid doctors to accurately diagnose the patient’s cardiac condition. Echocardiogram and angiogram (MRI, CT, etc.) are the most widely used Imaging in Structural Heart Disease modalities that assess the cardiac structure and identify narrowing or blockage of blood vessels. Rising number of minimally invasive procedures such as Transcatheter Aortic Valve Replacement (TAVR), advances in the techniques, and increasing government support for RD activities in the cardiology field create further growth opportunities for players in the global Imaging in Structural Heart Disease market over the forecast period.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/4100
Some Key Highlights From the Report:
- The heart valve devices segment is expected to dominate other product type segments in terms of revenue share during the forecast period. Growth of this segment is driven by rapidly growing number of TAVR procedures, surging adoption of TAVR techniques for their long-term durability and efficacy, and favorable regulatory policies.
- Based on imaging modality, the echocardiogram segment is expected to account for largest revenue share over the forecast years. Increasing incidence of structural and congenital heart diseases, augmented need for effective imaging and diagnosis of these diseases, rising use of echocardiograms in intraprocedural monitoring, and advantages such as real-time monitoring and high-quality images are the most crucial factors expected to fuel this segment’s growth.
- The North America Imaging in Structural Heart Disease market accounted for largest revenue share in 2020. Market growth is driven by rising prevalence of structural and congenital heart diseases, increasing demand for advanced cardiac imaging solutions, and awareness about cardiac health.
Competitive Outlook of the Global Imaging in Structural Heart Disease Market
The globla Imaging in Structural Heart Disease market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Imaging in Structural Heart Disease market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.
Top Companies Profiled in the Report:
Koninklijke Philips N.V., Boston Scientific Corporation, CryoLife, Inc., Abbott Laboratories, Siemens Healthineers GmbH, Toshiba Corporation, Medtronic Plc, CardioComm Solutions Inc., Edwards Lifesciences Corporation, Circle Cardiovascular Imaging, Inc., LivaNova PLC, Integer Holdings Corporation, HeartSciences, TomTec Imaging Systems GmbH, Micro Interventional Devices, Inc., Braile Biomédica, Lepu Medical Technology Co., Ltd., Shimadzu Corporation, 3mensio Medical Imaging BV, TTK Healthcare Limited, Pie Medical Imaging B.V., and Aran Biomedical Teoranta.
Imaging in Structural Heart Disease Market Segmentation:
By Product Type (Revenue, USD Billion; 2018-2028)
- Heart Valve Devices
- Transcatheter Heart Valves
- Surgical Heart Valves
- Occluders and Delivery Systems
- Annuloplasty Rings
- Others
By Imaging Modality (Revenue, USD Billion; 2018-2028)
- Echocardiogram
- Angiogram
- MRI (Magnetic Resonance Imaging)
- CT (Computed Tomography)
By Procedure Type (Revenue, USD Billion; 2018-2028)
- Transcatheter Aortic Valve Replacement (TAVR)
- Surgical Aortic Valve Replacement (SAVR)
- Transcatheter Mitral Valve Repair (TMVR)
- Left Atrial Appendage Closure (LAAC)
- Annuloplasty
- Valvuloplasty
- Others
By Application (Revenue, USD Billion; 2018-2028)
- Diagnosis
- Surgical Applications
By End-user (Revenue, USD Billion; 2018-2028)
- Hospitals
- Specialty clinics
- Cardiac centers
- Diagnostic centers
- Ambulatory surgical centers
- Catheterization laboratories
- Others
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/4100
The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.
Key Regional Markets Covered in the Report:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Spain, France, BENELUX, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of Asia Pacific)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East Africa)
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4100
Thank you for reading our report. To know more about the customization of the report, please get in touch with us and our team will ensure the report is suited to your requirements.
Get Explore Latest Research Report by Reports and Data:
Gastrointestinal Cancer Drugs Market @ https://www.biospace.com/article/ongoing-trends-in-the-gastrointestinal-cancer-drugs-market-and-forecast-analysis-by-2021-2028/
Bone Allografts and Xenografts Market @ https://www.biospace.com/article/bone-allografts-and-xenografts-industry-size-2021-2028-rising-demand-for-a-variety-of-orthopaedics-operations-is-one-of-the-main-factors-expected-to-drive-market-revenue-growth-says-reports-and-data/
Targeted RNA Sequencing Market @ https://www.biospace.com/article/targeted-rna-sequencing-market-size-share-growth-trends-growth-analysis-by-2021-2028/
Vaginal Pessary Market @ https://www.biospace.com/article/vaginal-pessary-market-size-growth-research-physical-characteristics-applications-and-forecast-analysis-by-2021-2028/
Intra Oral Scanners for Digital Impression Market @ https://www.biospace.com/article/intra-oral-scanners-for-digital-impression-market-trends-2021-industry-size-share-growth-and-forecast-analysis-by-2028-rnd/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
